Differences were found in molecular subtype between DCIS and invasive ductal carcinoma, as well as a high rate of multicentricity/multifocality and a strong association with HER2-positivity; therefore, further studies on the subject are required. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.